HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTFA requests $5 mil. in additional FDA appropriations for cosmetics regulatory program.

This article was originally published in The Rose Sheet

Executive Summary

CTFA REQUESTS ADDITIONAL $5 MIL. IN FDA APPROPRIATIONS FOR COSMETICS regulatory programs in March 31 testimony submitted by Cosmetic, Toiletry and Fragrance Association President Edward Kavanaugh to the House Appropriations/ Agriculture Subcommittee hearing on the FDA fiscal 1999 budget. Stressing the need for the additional funding, the trade association maintains a larger budget would be "essential to ensure continuing confidence in the safety of personal care products." The funding "should be provided through increased appropriations rather than through reallocation of existing resources or through user fees," the trade group asserts. However, "if increased appropriations are not possible, we ask that you instead reallocate and expressly earmark $5 mil. for the regulatory program for cosmetics" within the Center for Food Safety & Applied Nutrition, Kavanaugh urges in prepared testimony.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005283

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel